Progenity starts oral biologic trial in ulcerative colitis
To view this email as a web page, click here

Today's Rundown

Featured Story

Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa

Sanofi has turned to Blackstone Life Sciences for help developing a subcutaneous formulation of multiple myeloma drug Sarclisa. Blackstone is putting up $300 million to fund development of the formulation in return for a chance to receive royalties on future subcutaneous sales.

read more

Top Stories

Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact

Novo Nordisk has expanded its drug delivery collaboration with Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH). Building on advances such as the SOMA robotic pill, the partners will work on bioelectronics, biosensors and stimuli-responsive delivery devices.

read more

Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test

Progenity is advancing its oral biologic drug delivery project using the successful completion of its study in healthy volunteers as a launchpad for a clinical trial in patients with ulcerative colitis. 

read more

MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial  

Exact Therapeutics’ attempt to get its solid tumor clinical trial back on track has hit a snag, with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) asking for information on the ultrasound system used to activate the therapy.

read more

Incyte's Opzelura slapped with vitiligo delay amid topical JAK's eczema launch

The FDA has delayed its decision on Incyte’s Opzelura in vitiligo by three months. The regulator now plans to deliver a verdict on the topical JAK inhibitor, also known as ruxolitinib cream, by July 18, Incyte said in a release. 

read more

Resources

Industry Report: The Top Four Barriers to Successful KOL Engagement

Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now.

eBook: Leveraging Clinical Data for Study Success

The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates.

Whitepaper: Autologous CAR T-Cell Manufacturing: Semiautomatic, Closed, Modular Workflow

Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Whitepaper: Top 5 Challenges Of Decentralized Clinical Trials And How To Overcome Them

How to overcome top challenges faced in decentralized trials.

Paid Marketplace: United Cargo: Providing comprehensive solutions for the most critical shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events